Artiva Biotherapeutics Inc. (ARTV)

$11.77 -0.23 (-1.92%)
Market Cap N/A
Revenue (ttm) 33.49M
Net Income (ttm) -27.70M
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 342,500
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Artiva Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing natural killer (NK) cell-based therapies for patients suffering from autoimmune diseases and cancers. Its lead product candidate includes AlloNK, an off-the-shelf NK cell therapy for patients with autoimmune diseases and cancers, such as rheumatoid arthritis, systemic lupus erythematosus, lupus nephritis, rheumatoid arthritis, pemphigus vulgaris, the anti-neutrophil cytoplasmic antibody -associated vascul...

Industry: Biotechnology
Sector: Healthcare
Phone: 858 267 4467
Address:
5505 Morehouse Drive, Suite 100, San Diego, United States
_ShadowKings
_ShadowKings Apr. 16 at 11:10 PM
AMS ✅ Next 200%+ runner, don't say I didn't tell u!! AMS getting ready for a major breakout. This 3M floater can be the next monster runner. Markets hot, AMS is next to squeeze. $DARE $ACHV $GLND $ARTV //.12
0 · Reply
MMCGON333
MMCGON333 Apr. 16 at 10:48 PM
$ARTV I bought at $12.15. Probably not the best decision I have ever made but torn about selling it now or waiting until tomorrow.
0 · Reply
ShadowKings
ShadowKings Apr. 16 at 8:27 PM
Low float tickers are hot!! Taking off one by one! Seems like they are going to send AMS ✅ next! Pressure is building on AMS right now!! Only 3M float, can move up very quick. Be sure to be early, AMS ✅can be a big runner. $GLD $FLYT $FLY $ARTV /..1211
0 · Reply
KUMO2026
KUMO2026 Apr. 16 at 7:53 PM
$ARTV very nice move on this break out
0 · Reply
ap20
ap20 Apr. 16 at 7:45 PM
$ARTV I looked away for a bit and missed the 11’s. Sort of a great rip-off.
0 · Reply
RETAlerts
RETAlerts Apr. 16 at 7:33 PM
$ARTV breaking out on volume. Float's tight and this thing's moving. That 14.4% isn't noise.
0 · Reply
swinda42
swinda42 Apr. 16 at 7:07 PM
$ARTV how high do u think it will go
1 · Reply
TheTeamArctic
TheTeamArctic Apr. 16 at 7:03 PM
$EVTL $ARTV $LESL $PDC )F
0 · Reply
_TeamArctic
_TeamArctic Apr. 16 at 5:57 PM
$NKTR $VWAV $ARTV $BTQ xl
0 · Reply
_TeamArctic
_TeamArctic Apr. 16 at 5:45 PM
$GNLN $AFJK $ARTV $MNTS DO
0 · Reply
Latest News on ARTV
Artiva Biotherapeutics to Participate in the 25th Annual Needham Virtual Healthcare Conference

Apr 8, 2026, 8:00 AM EDT - 8 days ago

Artiva Biotherapeutics to Participate in the 25th Annual Needham Virtual Healthcare Conference

Artiva Biotherapeutics Reports Full Year 2025 Financial Results and Recent Business Highlights

Mar 10, 2026, 4:05 PM EDT - 5 weeks ago

Artiva Biotherapeutics Reports Full Year 2025 Financial Results and Recent Business Highlights

Artiva Biotherapeutics to Participate in the TD Cowen 46th Annual Health Care Conference

Feb 25, 2026, 8:00 AM EST - 7 weeks ago

Artiva Biotherapeutics to Participate in the TD Cowen 46th Annual Health Care Conference

Artiva Biotherapeutics Announces Appointment of Thad Huston as Chief Financial Officer and Award of Inducement Grant

Feb 24, 2026, 8:00 AM EST - 7 weeks ago

Artiva Biotherapeutics Announces Appointment of Thad Huston as Chief Financial Officer and Award of Inducement Grant

Artiva Biotherapeutics Announces Appointment of Elaine Sorg to Board of Directors

Feb 19, 2026, 8:00 AM EST - 2 months ago

Artiva Biotherapeutics Announces Appointment of Elaine Sorg to Board of Directors

Artiva Biotherapeutics Announces Upcoming Presentations at the 2026 Transplantation & Cellular Therapy Meetings of ASTCT® and CIBMTR® (Tandem Meetings) Highlighting Cost-Effectiveness of AlloNK in a Community Rheumatology Practice and Continued Durability of AlloNK in NHL

Jan 21, 2026, 8:00 AM EST - 3 months ago

Artiva Biotherapeutics Announces Upcoming Presentations at the 2026 Transplantation & Cellular Therapy Meetings of ASTCT® and CIBMTR® (Tandem Meetings) Highlighting Cost-Effectiveness of AlloNK in a Community Rheumatology Practice and Continued Durability of AlloNK in NHL

Artiva Biotherapeutics Announces Positive Initial Safety and Translational Data Supporting Deep B-Cell Depletion with AlloNK® in Autoimmune Disease

Nov 12, 2025, 7:20 AM EST - 5 months ago

Artiva Biotherapeutics Announces Positive Initial Safety and Translational Data Supporting Deep B-Cell Depletion with AlloNK® in Autoimmune Disease

Artiva Biotherapeutics Reports Third Quarter 2025 Financial Results and Recent Business Highlights

Nov 12, 2025, 7:00 AM EST - 5 months ago

Artiva Biotherapeutics Reports Third Quarter 2025 Financial Results and Recent Business Highlights

Artiva Biotherapeutics to Host Virtual Event Discussing Initial Safety and Translational Data in up to 32 Patients with Autoimmune Disease Treated with AlloNK®

Nov 3, 2025, 4:05 PM EST - 5 months ago

Artiva Biotherapeutics to Host Virtual Event Discussing Initial Safety and Translational Data in up to 32 Patients with Autoimmune Disease Treated with AlloNK®

Artiva Biotherapeutics to Participate in Upcoming Investor Conferences in November

Oct 30, 2025, 4:17 PM EDT - 6 months ago

Artiva Biotherapeutics to Participate in Upcoming Investor Conferences in November

Artiva Biotherapeutics Announces Refractory Rheumatoid Arthritis as Lead Indication, Upcoming Data Releases, and Corporate Update

Oct 16, 2025, 4:05 PM EDT - 6 months ago

Artiva Biotherapeutics Announces Refractory Rheumatoid Arthritis as Lead Indication, Upcoming Data Releases, and Corporate Update

Artiva Biotherapeutics to Participate in the Cantor Global Healthcare Conference 2025

Aug 25, 2025, 4:05 PM EDT - 8 months ago

Artiva Biotherapeutics to Participate in the Cantor Global Healthcare Conference 2025

Artiva Biotherapeutics Reports Second Quarter 2025 Financial Results, Recent Business Highlights

Aug 6, 2025, 4:05 PM EDT - 9 months ago

Artiva Biotherapeutics Reports Second Quarter 2025 Financial Results, Recent Business Highlights

Artiva Biotherapeutics to Participate in the Jefferies Global Healthcare Conference

May 28, 2025, 4:05 PM EDT - 11 months ago

Artiva Biotherapeutics to Participate in the Jefferies Global Healthcare Conference

Artiva Biotherapeutics Announces Longer-term Phase 1/2 Data Demonstrating Prolonged Durability for AlloNK® in Combination with Rituximab in Patients with B-cell-Non-Hodgkin Lymphoma at the ASGCT 28th Annual Meeting

May 13, 2025, 4:05 PM EDT - 1 year ago

Artiva Biotherapeutics Announces Longer-term Phase 1/2 Data Demonstrating Prolonged Durability for AlloNK® in Combination with Rituximab in Patients with B-cell-Non-Hodgkin Lymphoma at the ASGCT 28th Annual Meeting

Artiva Biotherapeutics Reports First Quarter 2025 Financial Results, Recent Business Highlights

May 8, 2025, 8:00 AM EDT - 1 year ago

Artiva Biotherapeutics Reports First Quarter 2025 Financial Results, Recent Business Highlights

Artiva Biotherapeutics to Present Longer-term Phase 1/2 Data for AlloNK® in Combination with Rituximab in Patients with B-cell-Non-Hodgkin Lymphoma at the ASGCT 28th Annual Meeting

Apr 28, 2025, 4:35 PM EDT - 1 year ago

Artiva Biotherapeutics to Present Longer-term Phase 1/2 Data for AlloNK® in Combination with Rituximab in Patients with B-cell-Non-Hodgkin Lymphoma at the ASGCT 28th Annual Meeting

Artiva Biotherapeutics Appoints Subhashis Banerjee, M.D., as Chief Medical Officer

Apr 8, 2025, 4:05 PM EDT - 1 year ago

Artiva Biotherapeutics Appoints Subhashis Banerjee, M.D., as Chief Medical Officer

Artiva Biotherapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference

Mar 31, 2025, 4:05 PM EDT - 1 year ago

Artiva Biotherapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference

Artiva Biotherapeutics Reports Full Year 2024 Financial Results and Recent Business Highlights

Mar 24, 2025, 4:05 PM EDT - 1 year ago

Artiva Biotherapeutics Reports Full Year 2024 Financial Results and Recent Business Highlights

Artiva Biotherapeutics to Participate in the TD Cowen 45th Annual Health Care Conference

Feb 20, 2025, 4:05 PM EST - 1 year ago

Artiva Biotherapeutics to Participate in the TD Cowen 45th Annual Health Care Conference

Artiva Biotherapeutics Expands Board of Directors with Appointment of Dan Baker, M.D.

Jan 29, 2025, 4:05 PM EST - 1 year ago

Artiva Biotherapeutics Expands Board of Directors with Appointment of Dan Baker, M.D.

Artiva Biotherapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights

Nov 12, 2024, 4:05 PM EST - 1 year ago

Artiva Biotherapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights

Artiva Biotherapeutics to Participate in the Jefferies London Healthcare Conference

Nov 11, 2024, 4:05 PM EST - 1 year ago

Artiva Biotherapeutics to Participate in the Jefferies London Healthcare Conference

Artiva Biotherapeutics Appoints Alison Moore, Ph.D., to Its Board of Directors

Oct 22, 2024, 4:05 PM EDT - 1 year ago

Artiva Biotherapeutics Appoints Alison Moore, Ph.D., to Its Board of Directors

Artiva Biotherapeutics to Participate in the 2024 Cantor Fitzgerald Global Healthcare Conference

Sep 10, 2024, 4:05 PM EDT - 1 year ago

Artiva Biotherapeutics to Participate in the 2024 Cantor Fitzgerald Global Healthcare Conference

Artiva Biotherapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights

Aug 29, 2024, 4:05 PM EDT - 1 year ago

Artiva Biotherapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights

Artiva Biotherapeutics' Investigational Scalable Cell Therapies For Autoimmune Disorders, Analyst Initiate With Bullish Pitch

Aug 13, 2024, 2:14 PM EDT - 1 year ago

Artiva Biotherapeutics' Investigational Scalable Cell Therapies For Autoimmune Disorders, Analyst Initiate With Bullish Pitch

Artiva Biotherapeutics Announces Pricing of Upsized $167.0 Million Initial Public Offering

Jul 18, 2024, 7:08 PM EDT - 1 year ago

Artiva Biotherapeutics Announces Pricing of Upsized $167.0 Million Initial Public Offering

_ShadowKings
_ShadowKings Apr. 16 at 11:10 PM
AMS ✅ Next 200%+ runner, don't say I didn't tell u!! AMS getting ready for a major breakout. This 3M floater can be the next monster runner. Markets hot, AMS is next to squeeze. $DARE $ACHV $GLND $ARTV //.12
0 · Reply
MMCGON333
MMCGON333 Apr. 16 at 10:48 PM
$ARTV I bought at $12.15. Probably not the best decision I have ever made but torn about selling it now or waiting until tomorrow.
0 · Reply
ShadowKings
ShadowKings Apr. 16 at 8:27 PM
Low float tickers are hot!! Taking off one by one! Seems like they are going to send AMS ✅ next! Pressure is building on AMS right now!! Only 3M float, can move up very quick. Be sure to be early, AMS ✅can be a big runner. $GLD $FLYT $FLY $ARTV /..1211
0 · Reply
KUMO2026
KUMO2026 Apr. 16 at 7:53 PM
$ARTV very nice move on this break out
0 · Reply
ap20
ap20 Apr. 16 at 7:45 PM
$ARTV I looked away for a bit and missed the 11’s. Sort of a great rip-off.
0 · Reply
RETAlerts
RETAlerts Apr. 16 at 7:33 PM
$ARTV breaking out on volume. Float's tight and this thing's moving. That 14.4% isn't noise.
0 · Reply
swinda42
swinda42 Apr. 16 at 7:07 PM
$ARTV how high do u think it will go
1 · Reply
TheTeamArctic
TheTeamArctic Apr. 16 at 7:03 PM
$EVTL $ARTV $LESL $PDC )F
0 · Reply
_TeamArctic
_TeamArctic Apr. 16 at 5:57 PM
$NKTR $VWAV $ARTV $BTQ xl
0 · Reply
_TeamArctic
_TeamArctic Apr. 16 at 5:45 PM
$GNLN $AFJK $ARTV $MNTS DO
0 · Reply
SannieVerraderlijk
SannieVerraderlijk Apr. 16 at 3:28 PM
$ARTV Out, so long and thanks for all the fish
1 · Reply
KUMO2026
KUMO2026 Apr. 16 at 2:03 PM
$ARTV swing trade into final push
0 · Reply
Papermoon347
Papermoon347 Apr. 16 at 1:57 PM
$ARTV Honesty hope when results come out its not sell on the news .
0 · Reply
StockMacroView
StockMacroView Apr. 16 at 2:11 AM
$ARTV and $ACET are officially making allogeneic cell therapy the gold standard for autoimmune treatment. Between ARTV ’s AlloNK platform and ACET ’s gamma delta T-cell tech, these "off-the-shelf" solutions are crushing the limitations of old-school CAR-T. We are witnessing a massive comeback—this is the future of immunology. 👉Click to view @StockMacroView for timely updates amid the volatility.
0 · Reply
belugatrade
belugatrade Apr. 15 at 4:41 PM
$ARTV expanding
0 · Reply
BrianRix
BrianRix Apr. 15 at 2:51 PM
$ARTV should have bought at 6 last week. Now i don't want to chase
2 · Reply
iQuicky
iQuicky Apr. 15 at 2:23 PM
$ARTV support cure cancer companies
0 · Reply
swinda42
swinda42 Apr. 15 at 12:39 PM
$ARTV going to the moon
0 · Reply
Astrid00
Astrid00 Apr. 9 at 3:41 PM
$ARTV $BTQ $NKTR $VWAV
0 · Reply
BladeWarden
BladeWarden Apr. 9 at 3:30 PM
$NKTR $VWAV $ARTV $BTQ •45•
0 · Reply
focafoca99
focafoca99 Apr. 8 at 7:59 PM
$ARTV is just flagging its participation in the Needham virtual healthcare conference.
0 · Reply
Papermoon347
Papermoon347 Apr. 7 at 11:18 AM
$ARTV Seems like its getting ready to explode! I believe if it pulls back first it will be very little I am waiting to add today ! Even with a bad market I bet we finish green today !
0 · Reply